Related Experiment Video
Updated: Jul 10, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Metastatic suppressor genes inactivated by aberrant methylation in gastric cancer
1Department of Surgical Oncology, the First Affiliated Hospital, China Medical University, Shenyang 110001, Liaoning Province, China.
Aim:
To screen out the differentially methylated DNA sequences between gastric primary tumor and metastatic lymph nodes, test the methylation difference of gene PTPRG between primary gastric tumor and metastatic lymph nodes, and test the regulatory function of 5-aza-2'-deoxycytidine which is an agent with suppression on methylation and the level of methylation in gastric cancer cell line.
Methods:
Methylated DNA sequences in genome were enriched with methylated CpG islands amplification (MCA) to undergo representational difference analysis (RDA), with MCA production of metastatic lymph nodes as tester and that of primary tumor as driver. The obtained differentially methylated fragments were cloned and sequenced to acquire the base sequence, which was analyzed with bioinformatics. With methylation-specific PCR (MSP) and RT-PCR, methylation difference of gene PTPRG was detected between primary tumor and metastatic lymph nodes in 36 cases of gastric cancer. Methylation of gene PTPRG and its regulated expression were observed in gastric cancer cell line before and after being treated with methylation-suppressive agent.
Results:
Nineteen differentially methylated sequences were obtained and located at 5' end, exons, introns and 3' end, in which KL59 was observed to be located at 9p21 as the first exon of gene p16 and KL22 to be located at promoter region of PRPRG. KL22, as the probes, was hybridized with driver, tester and 3-round RDA products respectively with all positive signals except with the driver. Significant difference was observed in both methylation rate of gene PTPRG and PTPRG mRNA expression rate between primary tumor and metastatic lymph nodes. Demethylation of gene PTPRG, with recovered expression of PTPRG mRNA, was observed after gastric cancer cell line being treated with methylation-suppressive agent.
Conclusion:
Difference exists in DNA methylation between primary tumor and metastatic lymph nodes of gastric cancer, with MCA-RDA as one of the good analytical methods. Significant difference exists in methylation of gene PTPRG between primary tumor and metastatic lymph nodes of gastric cancer. Methylation level in gastric cancer cell line can be decreased by 5-aza-2'-deoxycytidine, which is the methylation-suppressive agent, with PTPRG expression being recovered.
Insights
Gastric cancer shows distinct DNA methylation patterns between primary tumors and metastatic lymph nodes. The PTPRG gene
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Gastric cancer is a significant health concern with complex molecular underpinnings.
- Differential DNA methylation plays a crucial role in cancer progression and metastasis.
- Understanding methylation differences between primary tumors and metastatic sites is vital for targeted therapies.
Purpose of the Study:
- To identify differentially methylated DNA sequences between gastric primary tumors and metastatic lymph nodes.
- To investigate the methylation status and expression of the PTPRG gene in gastric cancer.
- To evaluate the effect of a methylation-suppressive agent on gastric cancer cell lines.
Main Methods:
- Methylated CpG islands amplification (MCA) coupled with representational difference analysis (RDA) for screening.
- Methylation-specific PCR (MSP) and RT-PCR to assess PTPRG gene methylation and mRNA expression.
- Treatment of gastric cancer cell lines with 5-aza-2'-deoxycytidine to observe methylation changes.
Main Results:
- Nineteen differentially methylated sequences were identified, including those in the PTPRG gene promoter region.
- Significant differences in PTPRG gene methylation and mRNA expression were observed between primary tumors and metastatic lymph nodes.
- Treatment with 5-aza-2'-deoxycytidine led to demethylation of PTPRG and recovery of its mRNA expression in cell lines.
Conclusions:
- Distinct DNA methylation profiles exist between primary gastric tumors and metastatic lymph nodes.
- The PTPRG gene is differentially methylated in gastric cancer, correlating with metastatic potential.
- Targeting DNA methylation with agents like 5-aza-2'-deoxycytidine can potentially restore PTPRG expression in gastric cancer.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
